Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Novak

Showing results (51-60 of 331) with videos related to

Pageof 34
Sort By:
Swiss Dental Journal|April 2, 2019
The dentigerous cyst: two different treatment options illustrated by two casesMario A. Bassetti, Johannes Kuttenberger, Jan Novak, et al.
Trends in Immunology|August 25, 2004
Therapeutic manipulation of iNKT cells in autoimmunity: modes of action and potential risksLennart T Mars, Jan Novak, Roland S Liblau, et al.
Immunopharmacology and Immunotoxicology|May 20, 2017
Clinical case: idelalisib-induced immunoglobulin flareJan Novak, Martin Havrda, Lubica Gaherova, et al.
Journal of the American Chemical Society|November 11, 2011
Membrane-assisted online renaturation for automated microfluidic lectin blottingMei He, Jan Novak, Bruce A Julian, et al.
Clinical and Experimental Medicine|September 28, 2015
Recovery of mucosal-associated invariant T cells after myeloablative chemotherapy and autologous peripheral blood stem cell transplantationJan Novak, Jan Dobrovolny, Jitka Brozova, et al.
Experientia Supplementum (2012)|October 23, 2021
Immunoglobulin A Glycosylation and Its Role in DiseaseAlyssa L Hansen, Colin Reily, Jan Novak, et al.
Nature Reviews. Nephrology|March 13, 2019
Glycosylation in health and diseaseColin Reily, Tyler J Stewart, Matthew B Renfrow, et al.
Leukemia & Lymphoma|April 7, 2012
Rituximab-induced coagulopathyJan Novak, Heidi Mocikova, Petr Pavlicek, et al.
Pediatric Nephrology (Berlin, Germany)|June 16, 2009
Pathogenesis of Henoch-Schönlein purpura nephritisKeith K Lau, Hitoshi Suzuki, Jan Novak, et al.
Immunity|December 14, 2002
NKT cells inhibit the onset of diabetes by impairing the development of pathogenic T cells specific for pancreatic beta cellsLucie Beaudoin, Véronique Laloux, Jan Novak, et al.
Pageof 34

Showing results (51-60 of 331) with videos related to

Sort By:
Pageof 34
Swiss Dental Journal|April 2, 2019
The dentigerous cyst: two different treatment options illustrated by two casesMario A. Bassetti, Johannes Kuttenberger, Jan Novak, et al.
Trends in Immunology|August 25, 2004
Therapeutic manipulation of iNKT cells in autoimmunity: modes of action and potential risksLennart T Mars, Jan Novak, Roland S Liblau, et al.
Immunopharmacology and Immunotoxicology|May 20, 2017
Clinical case: idelalisib-induced immunoglobulin flareJan Novak, Martin Havrda, Lubica Gaherova, et al.
Journal of the American Chemical Society|November 11, 2011
Membrane-assisted online renaturation for automated microfluidic lectin blottingMei He, Jan Novak, Bruce A Julian, et al.
Clinical and Experimental Medicine|September 28, 2015
Recovery of mucosal-associated invariant T cells after myeloablative chemotherapy and autologous peripheral blood stem cell transplantationJan Novak, Jan Dobrovolny, Jitka Brozova, et al.
Experientia Supplementum (2012)|October 23, 2021
Immunoglobulin A Glycosylation and Its Role in DiseaseAlyssa L Hansen, Colin Reily, Jan Novak, et al.
Nature Reviews. Nephrology|March 13, 2019
Glycosylation in health and diseaseColin Reily, Tyler J Stewart, Matthew B Renfrow, et al.
Leukemia & Lymphoma|April 7, 2012
Rituximab-induced coagulopathyJan Novak, Heidi Mocikova, Petr Pavlicek, et al.
Pediatric Nephrology (Berlin, Germany)|June 16, 2009
Pathogenesis of Henoch-Schönlein purpura nephritisKeith K Lau, Hitoshi Suzuki, Jan Novak, et al.
Immunity|December 14, 2002
NKT cells inhibit the onset of diabetes by impairing the development of pathogenic T cells specific for pancreatic beta cellsLucie Beaudoin, Véronique Laloux, Jan Novak, et al.
Pageof 34